Our evidence
| Status | Stage |
|---|---|
- Acupuncture and acupressure for premenstrual syndrome
- Acupuncture and assisted reproductive technology
- Acupuncture for dysmenorrhoea
- Acupuncture for menopausal hot flushes
- Acupuncture for pain in endometriosis
- Acupuncture for polycystic ovarian syndrome
- Acupuncture for uterine fibroids
- Add-back therapy with GnRH analogues for uterine fibroids
- Adhesion prevention agents for gynaecological surgery: an overview of Cochrane reviews
- Advanced sperm selection techniques for assisted reproduction
- Agents for ovarian stimulation for intrauterine insemination (IUI) in ovulatory women with infertility
- Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction
- Anti-adhesion therapy following operative hysteroscopy for treatment of female subfertility
- Anti-TNF-α treatment for pelvic pain associated with endometriosis
- Antibiotic prophylaxis for elective hysterectomy
- Antibiotics prior to or at the time of embryo transfer in ART
- Antidepressants for polycystic ovary syndrome
- Antifibrinolytics for heavy menstrual bleeding
- Antioxidants for female subfertility
- Antioxidants for male subfertility
- Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer)
- Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome
- Aromatase inhibitors for uterine fibroids
- Aspirin for in vitro fertilisation
- Assisted hatching on assisted conception (in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI))
- Assisted reproductive technologies for male subfertility
- Assisted reproductive technology: an overview of Cochrane Reviews
- Autologous platelet-rich plasma for assisted reproduction
- Barrier agents for adhesion prevention after gynaecological surgery
- Behavioural interventions for dysmenorrhoea
- Beta2-adrenoceptor agonists for dysmenorrhoea
- Bioidentical hormones for women with vasomotor symptoms
- Black cohosh (<I>Cimicifuga</I> spp.) for menopausal symptoms
- Blood biomarkers for the non-invasive diagnosis of endometriosis
- Brief co-incubation of sperm and oocytes for in vitro fertilization techniques
- Chinese herbal medicine for endometriosis
- Chinese herbal medicine for menopausal symptoms
- Chinese herbal medicine for premenstrual syndrome
- Chinese herbal medicine for primary dysmenorrhoea
- Chinese herbal medicine for subfertile women with polycystic ovarian syndrome
- Chinese herbal medicine in the treatment of ectopic pregnancy
- Cleavage-stage versus blastocyst-stage embryo transfer in assisted reproductive technology
- Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome
- Clomiphene citrate for unexplained subfertility in women
- Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome
- Combination of the non-invasive tests for the diagnosis of endometriosis
- Combined hormonal contraceptives for heavy menstrual bleeding
- Combined oral contraceptive pill for primary dysmenorrhoea
- Controlled ovarian stimulation protocols for assisted reproduction: a network meta-analysis
- Culture media for human pre-implantation embryos in assisted reproductive technology cycles
- Cycle regimens for frozen-thawed embryo transfer
- Cyclical progestogens for heavy menstrual bleeding
- Cyproterone acetate for hirsutism
- Danazol for heavy menstrual bleeding
- Danazol for pelvic pain associated with endometriosis
- Danazol for unexplained subfertility
- Danazol for uterine fibroids
- Day 5 versus day 3 embryo biopsy for preimplantation genetic testing for monogenic/single gene defects
- Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection
- Decision aids for the management of menopausal symptoms
- Dehydroepiandrosterone for women in the peri- or postmenopausal phase
- Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles
- Dietary supplements for dysmenorrhoea
- Dopamine agonists for preventing ovarian hyperstimulation syndrome
- Double versus single intrauterine insemination (IUI) in stimulated cycles for subfertile couples
- Early versus delayed oral feeding after major gynaecologic surgery
- Embryo freezing for preventing ovarian hyperstimulation syndrome
- Endometrial biomarkers for the non-invasive diagnosis of endometriosis
- Endometrial injection of embryo culture supernatant for subfertile women in assisted reproduction
- Endometrial injury for pregnancy following sexual intercourse or intrauterine insemination
- Endometrial injury in women attempting to conceive following sexual intercourse or intrauterine insemination: a collaborative individual participant data meta-analysis (IPD-MA)
- Endometrial injury in women undergoing in vitro fertilisation (IVF)
- Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
- Endometrial resection and ablation techniques for heavy menstrual bleeding
- Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding
- Endometriosis: an overview of Cochrane Reviews
- Excisional surgery versus ablative surgery for ovarian endometriomata
- Exercise for dysmenorrhoea
- Exercise for vasomotor menopausal symptoms
- Fluid and pharmacological agents for adhesion prevention after gynaecological surgery
- Follicular flushing during oocyte retrieval in assisted reproductive techniques
- Fresh versus frozen embryo transfers in assisted reproduction
- Glucocorticoid supplementation during ovarian stimulation for IVF or ICSI
- GM-CSF (granulocyte macrophage colony-stimulating factor) supplementation in culture media for women undergoing assisted reproduction
- GnRH agonists for uterine fibroids
- Gonadotrophin antagonists for pain associated with endometriosis
- Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction
- Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis
- Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
- Gonadotrophins for idiopathic male factor subfertility
- Gonadotrophins for ovulation induction in women with polycystic ovary syndrome
- Gonadotropin-releasing hormone (GnRH) analogues for premenstrual syndrome (PMS)
- Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology
- Gonadotropin-releasing hormone analogues for endometriosis
- Granulocyte-colony stimulating factor administration for subfertile women undergoing assisted reproduction
- Growth hormone for in vitro fertilisation (IVF)
- Heparin for assisted reproduction
- Herbal preparations for uterine fibroids
- High-intensity focused ultrasound for symptomatic uterine fibroids
- Hormonal treatment for uterine adenomyosis
- Hormone therapy for endometriosis and surgical menopause
- Hormone therapy for sexual function in perimenopausal and postmenopausal women
- Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency
- Hormone therapy in postmenopausal women and risk of endometrial hyperplasia
- Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation
- Hyaluronic acid in embryo transfer media for assisted reproductive technologies
- Hysterectomy versus hysterectomy plus oophorectomy for premenopausal women
- Hysterectomy with opportunistic salpingectomy versus hysterectomy alone
- Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities
- Imaging modalities for the non-invasive diagnosis of endometriosis
- Immune therapies for women with history of failed implantation undergoing IVF treatment
- In vitro fertilisation for unexplained subfertility
- In vitro fertilisation versus tubal reanastomosis (sterilisation reversal) for subfertility after tubal sterilisation
- In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction
- In-bag manual versus uncontained power morcellation for laparoscopic myomectomy
- Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI)
- Inositol for subfertile women with polycystic ovary syndrome
- Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
- Interventions commonly available during pandemics for heavy menstrual bleeding: an overview of Cochrane Reviews
- Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF)
- Interventions for fertility preservation in women with cancer undergoing chemotherapy
- Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta-analysis
- Interventions for improving reproductive outcomes in women with recurrent implantation failure undergoing assisted reproductive techniques
- Interventions for non-tubal ectopic pregnancy
- Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews
- Interventions for tubal ectopic pregnancy
- Interventions for unexplained infertility: a systematic review and network meta-analysis
- Interventions for uterine fibroids: an overview of Cochrane Reviews
- Interventions for women with endometrioma prior to assisted reproductive technology
- Interventions to reduce haemorrhage during myomectomy for fibroids
- Interventions to reduce shoulder pain following gynaecological laparoscopic procedures
- Intra-uterine insemination for unexplained subfertility
- Intra-uterine insemination versus timed intercourse or expectant management for cervical hostility in subfertile couples
- Intracytoplasmic sperm injection versus conventional in vitro fertilisation in couples with males presenting with normal total sperm count and motility
- Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction
- Intrauterine insemination versus fallopian tube sperm perfusion for non-tubal infertility
- Intrauterine insemination versus intracervical insemination in donor sperm treatment
- Laparoscopic entry techniques
- Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome
- Laparoscopic surgery for endometriosis
- Laparoscopy for the management of acute lower abdominal pain in women of childbearing age
- Laparoscopy versus laparotomy for benign ovarian tumour
- Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen
- Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery
- Levonorgestrel-releasing intrauterine system for endometrial hyperplasia
- Lifestyle changes in women with polycystic ovary syndrome
- Local oestrogen for vaginal atrophy in postmenopausal women
- Long versus short course treatment with metformin and clomiphene citrate for ovulation induction in women with PCOS
- Long-acting FSH versus daily FSH for women undergoing assisted reproduction
- Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis
- Long-term hormone therapy for perimenopausal and postmenopausal women
- Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis
- Low oxygen concentrations for embryo culture in assisted reproductive technologies
- Luteal phase support for assisted reproduction cycles
- Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse
- Metabolomics for improving pregnancy outcomes in women undergoing assisted reproductive technologies
- Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome
- Metformin for endometrial hyperplasia
- Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome
- Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome
- Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome
- Microwave therapy for cervical ectropion
- Mifepristone for uterine fibroids
- Minimally invasive surgical techniques versus open myomectomy for uterine fibroids
- Minimally invasive versus open surgery for reversal of tubal sterilization
- Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI)
- Natural cycle in vitro fertilisation (IVF) for subfertile couples
- Nifedipine for primary dysmenorrhoea
- Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome
- Non-hormonal therapy for hot flushes in postmenopausal women
- Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding
- Non-surgical interventions for the management of chronic pelvic pain
- Nonsteroidal anti-inflammatory drugs for assisted reproductive technology
- Nonsteroidal anti-inflammatory drugs for dysmenorrhoea
- Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis
- Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection
- Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution
- Oocyte activation for women following intracytoplasmic sperm injection (ICSI)
- Oral and intrauterine progestogens for atypical endometrial hyperplasia
- Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques
- Oral contraceptives containing drospirenone for premenstrual syndrome
- Oral contraceptives for pain associated with endometriosis
- Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation
- Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes
- Oral versus injectable ovulation induction agents for unexplained subfertility
- Ovarian cyst aspiration prior to in vitro fertilization treatment for subfertility
- Ovarian surgery for symptom relief in women with polycystic ovary syndrome
- Ovulation suppression for endometriosis for women with subfertility
- Ovulation triggers in anovulatory women undergoing ovulation induction
- Oxytocin antagonists for assisted reproduction
- Pain relief for outpatient hysteroscopy
- Pain relief for women undergoing oocyte retrieval for assisted reproduction
- Pain relief in hysterosalpingography
- Pentoxifylline for the treatment of endometriosis-associated pain and infertility
- Peri-implantation glucocorticoid administration for assisted reproductive technology cycles
- Perioperative interventions in pelvic organ prolapse surgery
- Pharmacological and non-pharmacological strategies for obese women with subfertility
- Pharmacological interventions for jet lag
- Phytoestrogens for menopausal vasomotor symptoms
- Post-embryo transfer interventions for assisted reproduction technology cycles
- Postoperative procedures for improving fertility following pelvic reproductive surgery
- Pre- and postsurgical medical therapy for endometriosis surgery
- Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding
- Preconception lifestyle advice for people with infertility
- Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation
- Preoperative medical therapy before surgery for uterine fibroids
- Preoperative ripening of the cervix before operative hysteroscopy
- Progestagens and anti-progestagens for pain associated with endometriosis
- Progesterone for premenstrual syndrome
- Progesterone receptor modulators for endometriosis
- Progestogen-releasing intrauterine systems for heavy menstrual bleeding
- Progestogens for hot flushes
- Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation as part of an assisted reproductive technology (ART) cycle
- Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy)
- Progestogens with or without oestrogen for irregular uterine bleeding associated with anovulation
- Prophylactic antibiotics for transcervical intrauterine procedures
- Psychological and educational interventions for subfertile men and women
- Pulsatile gonadotrophin releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome
- Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles
- Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles
- Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles
- Regular (ICSI) versus ultra-high magnification (IMSI) sperm selection for assisted reproduction
- Relaxation for perimenopausal and postmenopausal symptoms
- Screening hysteroscopy in subfertile women and women undergoing assisted reproduction
- Selective estrogen receptor modulators (SERMs) for uterine leiomyomas
- Selective oestrogen receptor modulators (SERMs) for endometriosis
- Selective progesterone receptor modulators (SPRMs) for uterine fibroids
- Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder
- Semen preparation techniques for intrauterine insemination
- Septum resection for women of reproductive age with a septate uterus
- Short-term and long-term effects of tibolone in postmenopausal women
- Slow freeze versus vitrification for embryo cryopreservation
- Soft versus firm catheters for intrauterine insemination
- Soft versus firm embryo transfer catheters for assisted reproductive technology
- Spinal manipulation for dysmenorrhoea
- Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne
- Statins for women with polycystic ovary syndrome not actively trying to conceive
- Surgery and minimally invasive treatments for uterine fibroids
- Surgery for tubal infertility
- Surgery for women with anterior compartment prolapse
- Surgery for women with apical vaginal prolapse
- Surgery for women with pelvic organ prolapse with or without stress urinary incontinence
- Surgery for women with posterior compartment prolapse
- Surgery versus medical therapy for heavy menstrual bleeding
- Surgical approach to hysterectomy for benign gynaecological disease
- Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea
- Surgical intervention versus expectant management for endometrial polyps in subfertile women
- Surgical interventions for the management of chronic pelvic pain in women
- Surgical or radiological treatment for varicoceles in subfertile men
- Surgical treatment for tubal disease in women due to undergo in vitro fertilisation
- Surgical treatment of fibroids for subfertility
- Synchronised approach for intrauterine insemination in subfertile couples
- Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction
- Techniques for pelvic surgery in subfertility
- Techniques for preparation prior to embryo transfer
- Techniques for surgical retrieval of sperm prior to intra-cytoplasmic sperm injection (ICSI) for azoospermia
- Temperature of embryo culture for assisted reproduction
- Testosterone for peri and postmenopausal women
- Three-dimensional saline infusion sonography compared to two-dimensional saline infusion sonography for the diagnosis of focal intracavitary lesions
- Thyroxine replacement for subfertile women with euthyroid autoimmune thyroid disease or subclinical hypothyroidism
- Time-lapse systems for embryo incubation and assessment in assisted reproduction
- Timed intercourse for couples trying to conceive
- Total versus subtotal hysterectomy for benign gynaecological conditions
- Transcutaneous electrical nerve stimulation (TENS) for pain control in women with primary dysmenorrhoea
- Transcutaneous electrical nerve stimulation for primary dysmenorrhoea
- Transvaginal mesh or grafts or native tissue repair for vaginal prolapse
- Trocar types in laparoscopy
- Tubal flushing for subfertility
- Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women
- Ultrasound-guided transvaginal ovarian needle drilling for clomiphene-resistant polycystic ovarian syndrome in subfertile women
- Urinary biomarkers for the non-invasive diagnosis of endometriosis
- Uterine artery embolization for symptomatic uterine fibroids
- Uterine distension media for outpatient hysteroscopy
- Vaginal energy-based devices for vulvovaginal dryness
- Vasodilators for women undergoing fertility treatment
- Visual tubal patency tests for tubal occlusion and hydrosalpinx
- Vitrification versus slow freezing for women undergoing oocyte cryopreservation
- Volume expanders for the prevention of ovarian hyperstimulation syndrome
- PELVIC PAIN (37)
- PAINFUL MENSTRUATION (EXCEPT WHEN CAUSED BY SPECIFIC PATHOLOGY) (15)
- Medical Therapies (4)
- Analgesics (0)
- Antispasmodics (1)
- Nonsteroidal anti-inflammatory drugs (1)
- Oral contraceptive pill (1)
- Progestogens (0)
- Vasodilators (1)
- Surgery (2)
- Presacral neurectomy (1)
- Laparoscopic uterine/uteroscral nerve ablation (1)
- Psychological Interventions (1)
- Transcutaneous electrical nerve stimulation (2)
- Alternative therapies (6)
- Acupuncture (2)
- Spinal manipulation (1)
- Herbal/Dietary Supplements (2)
- Exercise (1)
- Medical Therapies (4)
- ENDOMETRIOSIS/ADENOMYOSIS (20)
- Complementary therapies (2)
- Medical Therapies (14)
- Danazol (1)
- Gestrinone (0)
- Gonadotrophin releasing hormone (4)
- Hormone replacement therapy post pelvic clearance (surgical menopause) (0)
- Nonsteroidal anti-inflammatory drugs (1)
- Pre- and post- operative medical treatment (4)
- Anti-TNF-α treatment for pelvic pain associated with endometriosis
- Pentoxifylline for the treatment of endometriosis-associated pain and infertility
- Pre- and postsurgical medical therapy for endometriosis surgery
- Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery
- Progestogens (2)
- Oral contraceptive pill (1)
- Selective estrogen receptor modulators (SERMs) (1)
- Surgery (3)
- Drainage of endometriomas (0)
- Hysterectomy (with or without bilateral salpingo-oophorectomy) (0)
- Laparoscopic techniques - laser, diathermy (2)
- Laparoscopic uterine/uterosacral nerve ablation (1)
- Presacral neurectomy (0)
- Overview (1)
- PELVIC VENOUS CONGESTION (0)
- Medical Therapies (0)
- Gonadotrophin releasing hormones (0)
- Progestagens (0)
- Other hormonal/chemical agents (0)
- Vasoconstrictors (0)
- Surgery (0)
- Psychological Interventions (0)
- Psychotherapy (0)
- Medical Therapies (0)
- OTHER CHRONIC PELVIC PAIN (UNSPECIFIED BUT EXCLUDING PATHOLOGY) (2)
- Medical Therapies (0)
- Antidepressants (0)
- Local anaesthetic (0)
- Nonsteroidal anti-inflammatory drugs (0)
- Oral contraceptive pill (0)
- Psychological Interventions (0)
- Counselling (0)
- Photographic reinforcement (0)
- All (2)
- Medical Therapies (0)
- OVARIAN REMNANT SYNDROME (0)
- RESIDUAL OVARY SYNDROME (0)
- PAINFUL MENSTRUATION (EXCEPT WHEN CAUSED BY SPECIFIC PATHOLOGY) (15)
- DISORDERS OF MENSTRUAL CYCLING / OLIGO-AMENORRHOEA IN ASSOCIATION WITH: (14)
- POLYCYSTIC OVARIES (11)
- Medical Therapies (9)
- Antiandrogens (5)
- Dopamine agonists for preventing ovarian hyperstimulation syndrome
- Chinese herbal medicine for subfertile women with polycystic ovarian syndrome
- Lifestyle changes in women with polycystic ovary syndrome
- Antidepressants for polycystic ovary syndrome
- Statins for women with polycystic ovary syndrome not actively trying to conceive
- Gonadotrophin releasing hormones (0)
- Oral contraceptive pill (0)
- Progestogens (0)
- Retinoids (0)
- Insulin-sensitising drugs (4)
- Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
- Long versus short course treatment with metformin and clomiphene citrate for ovulation induction in women with PCOS
- Metformin for endometrial hyperplasia
- Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome
- Antiandrogens (5)
- Surgery (2)
- Medical Therapies (9)
- ELEVATED PROLACTIN LEVELS (0)
- Medical Therapies (0)
- Bromocriptine (0)
- Cabergoline (0)
- Surgery (0)
- Medical Therapies (0)
- WEIGHT-RELATED AMENORRHOEA (0)
- Medical Therapies (0)
- Antidepressants (0)
- Hormone replacement therapy (0)
- Oral contraceptive pill (0)
- Medical Therapies (0)
- FUNCTIONAL OVARIAN CYSTS (0)
- Medical Therapies (0)
- Gonadotrophin releasing hormones (0)
- Oral contraceptive pill (0)
- Other hormones (0)
- Surgery (0)
- Drainage (0)
- Medical Therapies (0)
- IRREGULAR MENSTRUAL BLEEDING (OLIGO-AMENORRHOEA, AMENORRHOEA) (1)
- OTHER ENDOCRINE DISORDERS (E.G. CONGENITAL ADRENAL HYPERPLASIA) (2)
- POLYCYSTIC OVARIES (11)
- HIRSUTISM AND RELATED ACNE (4)
- MEDICAL THERAPIES (4)
- Antiandrogens (2)
- Benzodiazepines (0)
- Cimetidine (0)
- Dopamine agonists (bromocriptine) (0)
- Gonadotrophin releasing hormones (0)
- Insulin-sensitising drugs (1)
- Oral contraceptive pill (1)
- Progestagens (0)
- Pyridostinine (0)
- Retinoids (0)
- SURGERY (0)
- Wedge biopsy (0)
- Ovarian drilling/diathermy (0)
- MEDICAL THERAPIES (4)
- EXCESSIVE MENSTRUAL BLEEDING (35)
- IDIOPATHIC EXCESSIVE MENSTRUAL BLEEDING (17)
- Investigation (1)
- Endometrial sampling techniques/dilatation and curettage (0)
- Ultrasound of endometrium (0)
- Hysteroscopy (1)
- Medical Therapies (10)
- Antifibrinolytic agents (1)
- Danazol (1)
- Hormone replacement therapy (0)
- Levonorgestrel IUCD (4)
- Levonorgestrel-releasing intrauterine system for endometrial hyperplasia
- Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen
- Oral and intrauterine progestogens for atypical endometrial hyperplasia
- Progestogen-releasing intrauterine systems for heavy menstrual bleeding
- Nonsteroidal anti-inflammatory drugs (1)
- Oral contraceptive pill (1)
- Other hormones (0)
- Progestagens (2)
- Surgery (6)
- Dilatation and curettage (0)
- Endometrial ablation or resection (all methods) (4)
- Endometrial resection and ablation techniques for heavy menstrual bleeding
- Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding
- Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding
- Surgery versus medical therapy for heavy menstrual bleeding
- Radiofrequency and microwave techniques (0)
- Hysterectomy (2)
- Psychological (0)
- Counselling (0)
- Investigation (1)
- Overview (2)
- TREATMENT OF FIBROIDS (15)
- Medical Therapies (9)
- Danazol (1)
- Gestrinone (0)
- Gonadotrophin releasing hormones (3)
- Nonsteroidal anti-inflammatory drugs (0)
- Progestogens (0)
- Other hormones (3)
- Herbal preparations (2)
- Overview (1)
- Surgery (5)
- Dilatation and curettage (0)
- Endoscopic techniques (0)
- HIFU (1)
- Hysterectomy (0)
- Myomectomy (3)
- UAE (1)
- Medical Therapies (9)
- ADENOMYOSIS (1)
- Medical therapies (1)
- IDIOPATHIC EXCESSIVE MENSTRUAL BLEEDING (17)
- CLIMACTERIC/MENOPAUSE (22)
- PREVENTION AND TREATMENT OF SHORT TERM PROBLEMS (12)
- Medical Treatments (7)
- Antidepressants (0)
- Antifibrinolytics (0)
- Antihypertensives (0)
- Clonidine (0)
- Hormone replacement therapy (5)
- Bioidentical hormones for women with vasomotor symptoms
- Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution
- Hormone therapy in postmenopausal women and risk of endometrial hyperplasia
- Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes
- Local oestrogen for vaginal atrophy in postmenopausal women
- Naloxone (0)
- Oral contraceptive pill (0)
- Essential fatty acids (e.g. evening primrose oil) (0)
- Other hormones (1)
- Non-hormonal therapy (1)
- Psychological Interventions (0)
- Exercise (1)
- Nutrition/Diet (1)
- Phytoestrogens (1)
- Alternative Therapies (3)
- Chinese herbs (1)
- Acupuncture (1)
- Other (1)
- Medical Treatments (7)
- PREVENTION AND TREATMENT OF MEDIUM TERM PROBLEMS (2)
- Medical Treatments (2)
- Hormone replacement therapy (2)
- Medical Treatments (2)
- PREVENTION AND TREATMENT OF LONG TERM PROBLEMS (8)
- Black cohosh (<I>Cimicifuga</I> spp.) for menopausal symptoms
- Decision aids for the management of menopausal symptoms
- Dehydroepiandrosterone for women in the peri- or postmenopausal phase
- Hormone therapy for sexual function in perimenopausal and postmenopausal women
- Hormone therapy for endometriosis and surgical menopause
- Long-term hormone therapy for perimenopausal and postmenopausal women
- Short-term and long-term effects of tibolone in postmenopausal women
- Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency
- PREVENTION AND TREATMENT OF SHORT TERM PROBLEMS (12)
- PREMENSTRUAL SYNDROME (includes cyclical mood swings and premenstrual exacerbation of symptoms) (7)
- PREVENTION AND TREATMENT (7)
- Medical Treatment (5)
- Anorexiants (0)
- Bromocriptine (0)
- Clonidine (0)
- Danazol (0)
- Diuretics (0)
- Dopamine (0)
- Essential fatty acids (e.g. evening primrose oil) (0)
- Gonadotrophin releasing hormones (1)
- Hormones (2)
- Minerals, supplements, or herbal treatments (e.g. magnesium) (0)
- Nonsteroidal anti-inflammatory drugs (0)
- Oral contraceptive pill (1)
- Psychotropic drugs (e.g. antidepressants, anti-anxiety agents, tranquillisers) (0)
- Vitamins (0)
- Other medications (1)
- Surgery (0)
- Hysterectomy (with and without bilateral salpingo-oophorectomy) (0)
- Psychological Interventions (0)
- Relaxation (0)
- Exercise (0)
- Nutrition (0)
- Alternative therapies (2)
- Acupuncture (1)
- Biofeedback (0)
- Chinese herbal medicine (1)
- Reflexology (0)
- Medical Treatment (5)
- PREVENTION AND TREATMENT (7)
- GYNAECOLOGICAL SURGERY (excluding malignant conditions but including complications after surgery) (20)
- MEDICAL THERAPIES (2)
- Antibiotics (2)
- Anticoagulants (0)
- Catheterisation (0)
- Local anaesthetics (0)
- Nonsteroidal anti-inflammatory drugs (0)
- SURGICAL INTERVENTIONS (1)
- Adhesion barriers (e.g. Interceed) (1)
- Diathermy (0)
- Intravenous fluids (0)
- Suture techniques (0)
- Wound closures (0)
- SURGICAL TECHNIQUES (15)
- Types of hysterectomy (5)
- Hysterectomy versus hysterectomy plus oophorectomy for premenopausal women
- Interventions for non-tubal ectopic pregnancy
- Total versus subtotal hysterectomy for benign gynaecological conditions
- Surgical approach to hysterectomy for benign gynaecological disease
- Hysterectomy with opportunistic salpingectomy versus hysterectomy alone
- Minimally invasive surgery (5)
- Outpatient hysteroscopy (5)
- Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities
- Pain relief for outpatient hysteroscopy
- Preoperative ripening of the cervix before operative hysteroscopy
- Screening hysteroscopy in subfertile women and women undergoing assisted reproduction
- Uterine distension media for outpatient hysteroscopy
- Types of hysterectomy (5)
- POST-OPERATIVE COMPLICATIONS FOLLOWING GYNAECOLOGICAL SURGERY (e.g. urinary retention, thromboembolism) (2)
- Medical Therapies (0)
- Antibiotics (0)
- Anticoagulants (0)
- Other (2)
- Medical Therapies (0)
- MEDICAL THERAPIES (2)
- PREMATURE OVARIAN FAILURE (0)
- EVALUATION OF MEASURES AIMED AT THE PREVENTION OF SUBFERTILITY (0)
- EVALUATION OF DIAGNOSTIC TECHNIQUES IN THE INVESTIGATION OR ASSESSMENT OF THE SUBFERTILE COUPLE (6)
- METHOD OF TESTING (6)
- Blood biomarkers for the non-invasive diagnosis of endometriosis
- Combination of the non-invasive tests for the diagnosis of endometriosis
- Day 5 versus day 3 embryo biopsy for preimplantation genetic testing for monogenic/single gene defects
- Endometrial biomarkers for the non-invasive diagnosis of endometriosis
- Imaging modalities for the non-invasive diagnosis of endometriosis
- Urinary biomarkers for the non-invasive diagnosis of endometriosis
- METHOD OF TESTING (6)
- EVALUATION OF SUBFERTILITY TREATMENTS RELATING TO THE FEMALE PARTNER (129)
- OLIGO/ANOVULATION. OVULATION INDUCTION BY MEANS OF (3)
- Medical therapies (3)
- Aromatase inhibitors (1)
- Weight adjustment (0)
- Anti oestrogens (clomiphene/tamoxifen/cyclophenyl) (1)
- GnRHas and gonadotrophins (1)
- Gonadotrophins (various preparations, regimes and modalities of administration) (0)
- Medical therapies (3)
- SUBFERTILITY ASSOCIATED WITH ENDOMETRIOSIS (5)
- Medical therapies (1)
- Danazol (1)
- GnRH agonists (0)
- Progestins (0)
- Surgery (open and laparoscopic) (0)
- Assisted conception techniques (3)
- Interventions for women with endometrioma prior to assisted reproductive technology
- Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis
- Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis
- Overview (1)
- Medical therapies (1)
- UNEXPLAINED SUBFERTILITY (15)
- Medical therapies (6)
- Danazol (1)
- Bromocriptine (0)
- Clomiphene (1)
- Gonadotrophins (1)
- Combinations of the above (1)
- Other (2)
- Assisted conception techniques (9)
- Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction
- Double versus single intrauterine insemination (IUI) in stimulated cycles for subfertile couples
- In vitro fertilisation for unexplained subfertility
- Post-embryo transfer interventions for assisted reproduction technology cycles
- Intra-uterine insemination for unexplained subfertility
- Intrauterine insemination versus fallopian tube sperm perfusion for non-tubal infertility
- Ovulation triggers in anovulatory women undergoing ovulation induction
- Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse
- Agents for ovarian stimulation for intrauterine insemination (IUI) in ovulatory women with infertility
- Medical therapies (6)
- INFERTILITY ASSOCIATED WITH POLYCYSTIC OVARY SYNDROME (10)
- Medical therapies (9)
- Clomiphene (1)
- Bromocriptine (0)
- Steroids (0)
- Gonadotrophins (hMG and FSH) (1)
- GnRH-agonists and gonadotrophins (1)
- Pulsatile LHRH (1)
- Insulin sensitising agents (5)
- Inositol for subfertile women with polycystic ovary syndrome
- Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
- Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome
- Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome
- Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome
- Surgery (1)
- Wedge resection (0)
- Laparoscopic ovarian "drilling" (1)
- Medical therapies (9)
- MECHANICAL INFERTILITY (TUBAL BLOCKAGE, PELVIC ADHESIONS) (10)
- Medical therapies (0)
- Surgery (10)
- Tubal flushing (1)
- Techniques of tubal surgery (5)
- In vitro fertilisation versus tubal reanastomosis (sterilisation reversal) for subfertility after tubal sterilisation
- Minimally invasive versus open surgery for reversal of tubal sterilization
- Surgery for tubal infertility
- Surgical treatment for tubal disease in women due to undergo in vitro fertilisation
- Techniques for pelvic surgery in subfertility
- Adjuvant peri-operative therapy to prevent adhesion (re)formation (2)
- Post-operative procedures to prevent adhesion (re) formation (2)
- SUBFERTILITY ASSOCIATED WITH FIBROIDS (2)
- ASSISTED CONCEPTION TECHNIQUES (58)
- Procedures (non-surgical) (55)
- Culture media or oocytes and/or embryos (17)
- Assisted hatching on assisted conception (in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI))
- Brief co-incubation of sperm and oocytes for in vitro fertilization techniques
- Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection
- Oxytocin antagonists for assisted reproduction
- Endometrial injection of embryo culture supernatant for subfertile women in assisted reproduction
- Follicular flushing during oocyte retrieval in assisted reproductive techniques
- Fresh versus frozen embryo transfers in assisted reproduction
- GM-CSF (granulocyte macrophage colony-stimulating factor) supplementation in culture media for women undergoing assisted reproduction
- Hyaluronic acid in embryo transfer media for assisted reproductive technologies
- Low oxygen concentrations for embryo culture in assisted reproductive technologies
- Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection
- Pain relief for women undergoing oocyte retrieval for assisted reproduction
- Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation
- Slow freeze versus vitrification for embryo cryopreservation
- Temperature of embryo culture for assisted reproduction
- Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women
- Cleavage-stage versus blastocyst-stage embryo transfer in assisted reproductive technology
- Luteal support (hCG; progesterone) (1)
- Technique modalities (IVF, GIFT, ZIFT) (11)
- Assisted reproductive technology: an overview of Cochrane Reviews
- Growth hormone for in vitro fertilisation (IVF)
- Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI)
- Immune therapies for women with history of failed implantation undergoing IVF treatment
- In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction
- Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF)
- Metabolomics for improving pregnancy outcomes in women undergoing assisted reproductive technologies
- Soft versus firm catheters for intrauterine insemination
- Soft versus firm embryo transfer catheters for assisted reproductive technology
- Techniques for preparation prior to embryo transfer
- Synchronised approach for intrauterine insemination in subfertile couples
- Ovarian stimulation protocols (drug regimes and modalities) (17)
- Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome
- Controlled ovarian stimulation protocols for assisted reproduction: a network meta-analysis
- Embryo freezing for preventing ovarian hyperstimulation syndrome
- Glucocorticoid supplementation during ovarian stimulation for IVF or ICSI
- Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles
- Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
- Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology
- Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation
- Interventions for fertility preservation in women with cancer undergoing chemotherapy
- Volume expanders for the prevention of ovarian hyperstimulation syndrome
- Long-acting FSH versus daily FSH for women undergoing assisted reproduction
- Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI)
- Natural cycle in vitro fertilisation (IVF) for subfertile couples
- Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques
- Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles
- Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles
- Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles
- Embryo cryopreservation (2)
- Endometrial preparation (7)
- Cycle regimens for frozen-thawed embryo transfer
- Endometrial injury in women undergoing in vitro fertilisation (IVF)
- Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
- Endometrial injury for pregnancy following sexual intercourse or intrauterine insemination
- Peri-implantation glucocorticoid administration for assisted reproductive technology cycles
- Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer)
- Vasodilators for women undergoing fertility treatment
- Culture media or oocytes and/or embryos (17)
- Surgery (3)
- Methods of oocyte retrieval (0)
- Methods of sperm preparation and oocyte insemination (2)
- Methods of embryo transfer (0)
- Tubal surgery (1)
- Procedures (non-surgical) (55)
- SPERM-MUCOUS INTERACTION IMPAIRMENT; "CERVICAL" INFERTILITY (1)
- Medical therapies (1)
- Mucous enhancing treatments (0)
- Artificial insemination by husband's sperm (AIH) (1)
- Other (0)
- Medical therapies (1)
- INFERTILITY TREATMENT FOR PREMATURE OVARIAN FAILURE (0)
- ECTOPIC PREGNANCY (2)
- OTHER (23)
- Acupuncture and assisted reproductive technology
- Acupuncture for polycystic ovarian syndrome
- Antibiotics prior to or at the time of embryo transfer in ART
- Autologous platelet-rich plasma for assisted reproduction
- Culture media for human pre-implantation embryos in assisted reproductive technology cycles
- Pharmacological and non-pharmacological strategies for obese women with subfertility
- Preconception lifestyle advice for people with infertility
- Endometrial injury in women undergoing in vitro fertilisation (IVF)
- Interventions for improving reproductive outcomes in women with recurrent implantation failure undergoing assisted reproductive techniques
- Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews
- Interventions for unexplained infertility: a systematic review and network meta-analysis
- Nonsteroidal anti-inflammatory drugs for assisted reproductive technology
- Ovarian cyst aspiration prior to in vitro fertilization treatment for subfertility
- Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation as part of an assisted reproductive technology (ART) cycle
- Psychological and educational interventions for subfertile men and women
- Surgical intervention versus expectant management for endometrial polyps in subfertile women
- Septum resection for women of reproductive age with a septate uterus
- Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction
- Thyroxine replacement for subfertile women with euthyroid autoimmune thyroid disease or subclinical hypothyroidism
- Time-lapse systems for embryo incubation and assessment in assisted reproduction
- Timed intercourse for couples trying to conceive
- Granulocyte-colony stimulating factor administration for subfertile women undergoing assisted reproduction
- Antioxidants for female subfertility
- OLIGO/ANOVULATION. OVULATION INDUCTION BY MEANS OF (3)
- EVALUATION OF SUBFERTILITY TREATMENTS RELATING TO THE MALE PARTNER (10)
- IDIOPATHIC OLIGO- ASTHENO- TERATOSPERMIA (1)
- Medical therapies (1)
- Antioestrogens (0)
- Androgens (0)
- Bromocriptine (0)
- Kinin- enhancing drugs (kallikrein) (0)
- Other medical treatments (1)
- Artificial insemination by husband (AIH) (0)
- Assisted conception techniques (0)
- Medical therapies (1)
- OLIGOSPERMIA ASSOCIATED WITH VARICOCELE (1)
- Medical therapies (0)
- Surgery (1)
- "Curative" varicocele treatment (1)
- Preventative varicocele treatment (0)
- ARTIFICIAL INSEMINATION BY DONOR (DI) (1)
- Type of semen used (fresh or frozen) (0)
- Site of insemination (intracervical or intrauterine) (1)
- Timing and number of inseminations (0)
- Cryopreservation methods (0)
- INFERTILITY ASSOCIATED WITH ANTISPERM ANTIBODIES (0)
- Medical therapies (0)
- Immuno modulating drugs (including steroids) (0)
- Treatment of antibody containing sperm samples (0)
- Artificial insemination (0)
- Assisted conception techniques (0)
- Medical therapies (0)
- IMPOTENCE (0)
- Medical therapies (0)
- Psychological interventions (0)
- HYPOGONADOTROPIC HYPOGONADISM (0)
- Weight adjustment (0)
- Psychological interventions (0)
- Drug treatment (0)
- ASSISTED CONCEPTION TECHNIQUES FOR MALE INFERTILITY (6)
- Sperm preparation techniques (1)
- Micro manipulation techniques (1)
- Intrauterine insemination (2)
- Sperm Retrieval Techniques (2)
- OTHER (1)
- IDIOPATHIC OLIGO- ASTHENO- TERATOSPERMIA (1)
- Surgical management of pelvic organ prolapse (6)
- Perioperative interventions in pelvic organ prolapse surgery
- Transvaginal mesh or grafts or native tissue repair for vaginal prolapse
- Surgery for women with pelvic organ prolapse with or without stress urinary incontinence
- Surgery for women with anterior compartment prolapse
- Surgery for women with apical vaginal prolapse
- Surgery for women with posterior compartment prolapse